Cardioprotective factors in postmenopausal women
DOI:
https://doi.org/10.35381/s.v.v7i1.2603Keywords:
Cardioprotective factors, postmenopausal women, comorbidity, (Source: DeCS)Abstract
Objective: to analyze cardioprotective factors in postmenopausal women from a literature review. Method: systematic review. Results and Conclusion: In postmenopausal women, it is important to incorporate physical exercise, balanced nutrition, and medical follow-up as essential cardioprotective measures, since exercise-induced cardioprotective factors contribute to cardiac repair in pathological conditions. With the increasing incidence of cardiovascular diseases, the concomitant mortality and morbidity impose enormous burdens on the quality of life and social costs.
Downloads
References
Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022; 21(1):68. doi:10.1186/s12933-022-01511-x
Senoner T, Dichtl W. Oxidative Stress in Cardiovascular Diseases: Still a Therapeutic Target? Nutrients. 2019; 11(9):2090. doi:10.3390/nu11092090
Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. Int J Mol Sci. 2021; 22(17):9221. doi:10.3390/ijms22179221
Jang AY, Han SH, Sohn IS, Oh PC, Koh KK. Lipoprotein(a) and cardiovascular diseases - Revisited. Circ J. 2020; 84(6):867-874. doi:10.1253/circj. CJ-20-0051
Kondo T, Nakano Y, Adachi S, Murohara T. Effects of Tobacco Smoking on Cardiovascular Disease. Circ J. 2019; 83(10):1980-1985. doi:10.1253/circj. CJ-19-0323
Cho L, Davis M, Elgendy I, et al. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75(20):2602-2618. doi: 10.1016/j.jacc.2020.03.060
Guo Y, Chen J, Qiu H. Novel Mechanisms of Exercise-Induced Cardioprotective Factors in Myocardial Infarction. Front Physiol. 2020; 11:199. doi:10.3389/fphys.2020.00199
Wang Y, Tian MM, Mi CJ, et al. Exercise protects the heart against myocardial infarction through upregulation of miR-1192. Biochem Biophys Res Commun. 2020; 521(4):1061-1069. doi: 10.1016/j.bbrc.2019.11.019
Huang G, Cheng Z, Hildebrand A, et al. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition. Theranostics. 2022; 12(9):4415-4430. doi:10.7150/thno.70821
Wu G, Zhang X, Gao F. The epigenetic landscape of exercise in cardiac health and disease. J Sport Health Sci. 2021; 10(6):648-659. doi: 10.1016/j.jshs.2020.12.003
Querio G, Geddo F, Antoniotti S, Gallo MP, Penna C. Sex and Response to Cardioprotective Conditioning Maneuvers. Front Physiol. 2021; 12:667961. Published 2021 May 14. doi:10.3389/fphys.2021.667961
Ruiz-Meana M, Boengler K, Garcia-Dorado D, et al. Ageing, sex, and cardioprotection. Br J Pharmacol. 2020; 177(23):5270-5286. doi:10.1111/bph.14951
Pauls SD, Du Y, Clair L, et al. Impact of Age, Menopause, and Obesity on Oxylipins Linked to Vascular Health. Arterioscler Thromb Vasc Biol. 2021; 41(2):883-897. doi:10.1161/ATVBAHA.120.315133
Raparelli V, Elharram M, Moura CS, et al. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus. J Am Heart Assoc. 2020; 9(1):e012940. doi:10.1161/JAHA.119.012940
Funck KL, Bjerg L, Isaksen AA, Sandbæk A, Grove EL. Gender disparities in time-to-initiation of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: a Danish nationwide cohort study. Cardiovasc Diabetol. 2022; 21(1):279. Published 2022 Dec 10. doi:10.1186/s12933-022-01713-3
Sárközy M, Márványkövi FM, Szűcs G, et al. Ischemic preconditioning protects the heart against ischemia-reperfusion injury in chronic kidney disease in both males and females. Biol Sex Differ. 2021; 12(1):49. Published 2021 Sep 6. doi:10.1186/s13293-021-00392-1
Dziedzic EA, Smyk W, Sowińska I, Dąbrowski M, Jankowski P. Serum Level of Vitamin D Is Associated with Severity of Coronary Atherosclerosis in Postmenopausal Women. Biology (Basel). 2021; 10(11):1139. Published 2021 Nov 5. doi:10.3390/biology10111139
Dziedzic EA, Gąsior JS, Pawłowski M, et al. Vitamin D level is associated with severity of coronary artery atherosclerosis and incidence of acute coronary syndromes in non-diabetic cardiac patients. Arch Med Sci. 2019; 15(2):359-368. doi:10.5114/aoms.2019.83291
Szulińska M, Łoniewski I, Skrypnik K, et al. Multispecies Probiotic Supplementation Favorably Affects Vascular Function and Reduces Arterial Stiffness in Obese Postmenopausal Women-A 12-Week Placebo-Controlled and Randomized Clinical Study. Nutrients. 2018; 10(11):1672. doi:10.3390/nu10111672
Szulińska M, Łoniewski I, van Hemert S, Sobieska M, Bogdański P. Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial. Nutrients. 2018; 10(6):773. Published 2018 Jun 15. doi:10.3390/nu10060773
Oliver-Williams C, Glisic M, Shahzad S, et al. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Hum Reprod Update. 2019; 25(2):257-271. doi:10.1093/humupd/dmy039
Azizian H, Khaksari M, Asadi Karam G, Esmailidehaj M, Farhadi Z. Cardioprotective and anti-inflammatory effects of G-protein coupled receptor 30 (GPR30) on postmenopausal type 2 diabetic rats. Biomed Pharmacother. 2018; 108:153-164. doi: 10.1016/j.biopha.2018.09.028
Maiello M, Cecere A, Zito A, Ciccone MM, Palmiero P. Low-dose Aspirin for Primary Prevention of Cardiovascular Events in Postmenopausal Women with Type-2 Diabetes: The Prescriptive Approach in the Real World. Int J Prev Med. 2021; 12:140. Published 2021 Oct 26. doi: 10.4103/ijpvm.IJPVM_365_19
Yan H, Yang W, Zhou F, et al. Estrogen Protects Cardiac Function and Energy Metabolism in Dilated Cardiomyopathy Induced by Loss of Cardiac IRS1 and IRS2. Circ Heart Fail. 2022; 15(6):e008758. doi:10.1161/CIRCHEARTFAILURE.121.008758
Abbas A, Patel N, Kazmi R, Mirza N, Miller R, Correia J. Diabetic Ketoacidosis-Induced Cardiomyopathy and Reversible Dialysis-Dependent Renal Failure With Successful Outcome: A Report of a Rare Case. Cureus. 2022; 14(11):e31711. doi:10.7759/cureus.31711
Mhanna M, Beran A, Srour O, Ghazaleh S, Elzanaty A. A Case of Takotsubo Cardiomyopathy Triggered by Diabetic Ketoacidosis and Hypothermia. Cureus. 2020; 12(10):e10842. Published 2020 Oct 7. doi:10.7759/cureus.10842
Ko SH, Kim HS. Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women. Nutrients. 2020; 12(1):202. doi:10.3390/nu12010202
Ko SH, Jung Y. Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women. Nutrients. 2021; 13(12):4556. doi:10.3390/nu13124556
Naftolin F, Friedenthal J, Nachtigall R, Nachtigall L. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment. F1000Res. 2019; 8:F1000 Faculty Rev-1576. Published 2019 Sep 3. doi:10.12688/f1000research.15548.
Anagnostis P, Lambrinoudaki I, Stevenson JC, Goulis DG. Menopause-associated risk of cardiovascular disease. Endocr Connect. 2022; 11(4):e210537. Published 2022 Apr 22. doi:10.1530/EC-21-0537
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Lizbeth Aracely Toapanta-Muso, Jissela-del-Carmen Silva-Acosta
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
